FI63937C - Foerfarande foer framstaellning av terapeutiskt anvaendbara feylpiperaziner - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara feylpiperaziner Download PDFInfo
- Publication number
- FI63937C FI63937C FI771287A FI771287A FI63937C FI 63937 C FI63937 C FI 63937C FI 771287 A FI771287 A FI 771287A FI 771287 A FI771287 A FI 771287A FI 63937 C FI63937 C FI 63937C
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- piperazine
- ylmethyl
- formula
- alkyl
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims description 56
- -1 is Q Chemical group 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 229930192474 thiophene Chemical group 0.000 claims description 5
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 4
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 3
- 125000004803 chlorobenzyl group Chemical group 0.000 claims description 3
- 239000012024 dehydrating agents Substances 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000002971 oxazolyl group Chemical group 0.000 claims description 3
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 101100177165 Caenorhabditis elegans har-1 gene Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 45
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 31
- 239000003921 oil Substances 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 8
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 4
- 229960000582 mepyramine Drugs 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- JJDXREXQSCIIJY-UHFFFAOYSA-N (2-amino-2-sulfanylideneethyl) acetate Chemical compound CC(=O)OCC(N)=S JJDXREXQSCIIJY-UHFFFAOYSA-N 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000460 chlorine Chemical group 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 2
- DOYNABJKDZARLF-UHFFFAOYSA-N 1-(3-bromophenyl)piperazine Chemical compound BrC1=CC=CC(N2CCNCC2)=C1 DOYNABJKDZARLF-UHFFFAOYSA-N 0.000 description 2
- AJRPYRKMJVWZDT-UHFFFAOYSA-N 2-(chloromethyl)-4-phenyl-1,3-thiazole Chemical compound S1C(CCl)=NC(C=2C=CC=CC=2)=C1 AJRPYRKMJVWZDT-UHFFFAOYSA-N 0.000 description 2
- YAUQKPYDLLXVFV-UHFFFAOYSA-N 2-[[4-(4-methoxyphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=CC(OC)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 YAUQKPYDLLXVFV-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- NSKIAVMDKCAZIK-UHFFFAOYSA-N 5-phenyl-2-[2-(4-phenylpiperazin-1-yl)ethyl]-1,3-oxazole Chemical compound C1CN(C=2C=CC=CC=2)CCN1CCC(O1)=NC=C1C1=CC=CC=C1 NSKIAVMDKCAZIK-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Inorganic materials [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- UNXITVZEJITWQA-UHFFFAOYSA-N n-phenyl-3-(4-phenylpiperazin-1-yl)propanamide Chemical compound C=1C=CC=CC=1NC(=O)CCN(CC1)CCN1C1=CC=CC=C1 UNXITVZEJITWQA-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- CVXGFPPAIUELDV-UHFFFAOYSA-N phenacylazanium;chloride Chemical compound [Cl-].[NH3+]CC(=O)C1=CC=CC=C1 CVXGFPPAIUELDV-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 150000003557 thiazoles Chemical class 0.000 description 2
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- TYUWZKSJURGPRJ-UHFFFAOYSA-N (4-phenyl-1,3-thiazol-2-yl)methanol Chemical compound S1C(CO)=NC(C=2C=CC=CC=2)=C1 TYUWZKSJURGPRJ-UHFFFAOYSA-N 0.000 description 1
- UYFPOLZTLYUSLH-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-4-[(5-phenylthiophen-2-yl)methyl]piperazine Chemical compound C1=C(Cl)C(Cl)=CC=C1N1CCN(CC=2SC(=CC=2)C=2C=CC=CC=2)CC1 UYFPOLZTLYUSLH-UHFFFAOYSA-N 0.000 description 1
- HNAQBPRWTFLAQL-UHFFFAOYSA-N 1-(3,4-dimethylphenyl)-4-[(5-methylfuran-2-yl)methyl]piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=C(C)C(C)=CC=2)CC1 HNAQBPRWTFLAQL-UHFFFAOYSA-N 0.000 description 1
- UFINBAXLPAKZNT-UHFFFAOYSA-N 1-(3-chlorophenyl)-4-[(5-phenylfuran-2-yl)methyl]piperazine;hydrochloride Chemical compound Cl.ClC1=CC=CC(N2CCN(CC=3OC(=CC=3)C=3C=CC=CC=3)CC2)=C1 UFINBAXLPAKZNT-UHFFFAOYSA-N 0.000 description 1
- XJNBQSFVLAYOFE-UHFFFAOYSA-N 1-(3-chlorophenyl)-4-[[5-[4-chloro-3-(trifluoromethyl)phenyl]furan-2-yl]methyl]piperazine;hydrochloride Chemical compound Cl.C1=C(Cl)C(C(F)(F)F)=CC(C=2OC(CN3CCN(CC3)C=3C=C(Cl)C=CC=3)=CC=2)=C1 XJNBQSFVLAYOFE-UHFFFAOYSA-N 0.000 description 1
- ZXXUKLNDVGZFLJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-[(5-methylfuran-2-yl)methyl]piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=CC(Cl)=CC=2)CC1 ZXXUKLNDVGZFLJ-UHFFFAOYSA-N 0.000 description 1
- MZHLZGFSJSXRKM-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-[(5-methylfuran-2-yl)methyl]piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=CC(F)=CC=2)CC1 MZHLZGFSJSXRKM-UHFFFAOYSA-N 0.000 description 1
- QEBDKGDXINTUQR-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-[(5-phenylthiophen-2-yl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1N1CCN(CC=2SC(=CC=2)C=2C=CC=CC=2)CC1 QEBDKGDXINTUQR-UHFFFAOYSA-N 0.000 description 1
- AVJKDKWRVSSJPK-UHFFFAOYSA-N 1-(4-fluorophenyl)piperazine Chemical compound C1=CC(F)=CC=C1N1CCNCC1 AVJKDKWRVSSJPK-UHFFFAOYSA-N 0.000 description 1
- RLABBVYISMVSTG-UHFFFAOYSA-N 1-(4-methoxyphenyl)-4-[(5-phenylthiophen-2-yl)methyl]piperazine Chemical compound C1=CC(OC)=CC=C1N1CCN(CC=2SC(=CC=2)C=2C=CC=CC=2)CC1 RLABBVYISMVSTG-UHFFFAOYSA-N 0.000 description 1
- SSASWPMHNMYMLZ-UHFFFAOYSA-N 1-(4-methylphenyl)-4-[(5-phenylfuran-2-yl)methyl]piperazine Chemical compound C1=CC(C)=CC=C1N1CCN(CC=2OC(=CC=2)C=2C=CC=CC=2)CC1 SSASWPMHNMYMLZ-UHFFFAOYSA-N 0.000 description 1
- CLHSRJATFSAGOO-UHFFFAOYSA-N 1-[(5-methylfuran-2-yl)methyl]-4-(4-methylphenyl)piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=CC(C)=CC=2)CC1 CLHSRJATFSAGOO-UHFFFAOYSA-N 0.000 description 1
- SMDQIPINFTZFKL-UHFFFAOYSA-N 1-[(5-methylfuran-2-yl)methyl]-4-[3-(trifluoromethyl)phenyl]piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=C(C=CC=2)C(F)(F)F)CC1 SMDQIPINFTZFKL-UHFFFAOYSA-N 0.000 description 1
- RFYYIDXQPJCCCF-UHFFFAOYSA-N 1-[(5-tert-butylfuran-2-yl)methyl]-4-(4-fluorophenyl)piperazine Chemical compound O1C(C(C)(C)C)=CC=C1CN1CCN(C=2C=CC(F)=CC=2)CC1 RFYYIDXQPJCCCF-UHFFFAOYSA-N 0.000 description 1
- PZSJVUAHKKNTIM-UHFFFAOYSA-N 1-[(5-tert-butylfuran-2-yl)methyl]-4-(4-methoxyphenyl)piperazine Chemical compound C1=CC(OC)=CC=C1N1CCN(CC=2OC(=CC=2)C(C)(C)C)CC1 PZSJVUAHKKNTIM-UHFFFAOYSA-N 0.000 description 1
- FTBQCVFOWMOGKH-UHFFFAOYSA-N 1-[(5-tert-butylfuran-2-yl)methyl]-4-(4-methylphenyl)piperazine Chemical compound C1=CC(C)=CC=C1N1CCN(CC=2OC(=CC=2)C(C)(C)C)CC1 FTBQCVFOWMOGKH-UHFFFAOYSA-N 0.000 description 1
- VBMQVEYCUGCGLQ-UHFFFAOYSA-N 1-[(5-tert-butylfuran-2-yl)methyl]-4-[3-(trifluoromethyl)phenyl]piperazine Chemical compound O1C(C(C)(C)C)=CC=C1CN1CCN(C=2C=C(C=CC=2)C(F)(F)F)CC1 VBMQVEYCUGCGLQ-UHFFFAOYSA-N 0.000 description 1
- COJBNLZBGPMVKZ-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-4-[(5-methylfuran-2-yl)methyl]piperazine Chemical compound O1C(C)=CC=C1CN1CCN(C=2C=C(C(Cl)=CC=2)C(F)(F)F)CC1 COJBNLZBGPMVKZ-UHFFFAOYSA-N 0.000 description 1
- YSLDKMWNNBFHHT-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-4-[(5-phenylthiophen-2-yl)methyl]piperazine Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(N2CCN(CC=3SC(=CC=3)C=3C=CC=CC=3)CC2)=C1 YSLDKMWNNBFHHT-UHFFFAOYSA-N 0.000 description 1
- XRJPVUYQSMDVTL-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-4-[[5-(3,4-dimethylphenyl)furan-2-yl]methyl]piperazine Chemical compound C1=C(C)C(C)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=C(C(Cl)=CC=2)C(F)(F)F)CC1 XRJPVUYQSMDVTL-UHFFFAOYSA-N 0.000 description 1
- HTGUJDLBZUXWFC-UHFFFAOYSA-N 1-[[5-(3,4-dimethylphenyl)furan-2-yl]methyl]-4-phenylpiperazine Chemical compound C1=C(C)C(C)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=CC=CC=2)CC1 HTGUJDLBZUXWFC-UHFFFAOYSA-N 0.000 description 1
- WSGOBNUYBARGTK-UHFFFAOYSA-N 1-[[5-(4-chlorophenyl)furan-2-yl]methyl]-4-[3-(trifluoromethyl)phenyl]piperazine;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC=CC(N2CCN(CC=3OC(=CC=3)C=3C=CC(Cl)=CC=3)CC2)=C1 WSGOBNUYBARGTK-UHFFFAOYSA-N 0.000 description 1
- ZZWNNIQNXFJHGR-UHFFFAOYSA-N 1-[[5-(4-methoxyphenyl)furan-2-yl]methyl]-4-(4-methylphenyl)piperazine Chemical compound C1=CC(OC)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=CC(C)=CC=2)CC1 ZZWNNIQNXFJHGR-UHFFFAOYSA-N 0.000 description 1
- JQZAAXONFICWOX-UHFFFAOYSA-N 1-[[5-(4-methoxyphenyl)furan-2-yl]methyl]-4-phenylpiperazine Chemical compound C1=CC(OC)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=CC=CC=2)CC1 JQZAAXONFICWOX-UHFFFAOYSA-N 0.000 description 1
- FWMBEVALSPDSOS-UHFFFAOYSA-N 1-[[5-[4-chloro-3-(trifluoromethyl)phenyl]furan-2-yl]methyl]-4-(4-methylphenyl)piperazine Chemical compound C1=CC(C)=CC=C1N1CCN(CC=2OC(=CC=2)C=2C=C(C(Cl)=CC=2)C(F)(F)F)CC1 FWMBEVALSPDSOS-UHFFFAOYSA-N 0.000 description 1
- SFWRBGUGIALACC-UHFFFAOYSA-N 1-phenyl-4-[(5-phenylfuran-2-yl)methyl]piperazine Chemical compound C=1C=C(C=2C=CC=CC=2)OC=1CN(CC1)CCN1C1=CC=CC=C1 SFWRBGUGIALACC-UHFFFAOYSA-N 0.000 description 1
- RAMJEMMYMBYKBU-UHFFFAOYSA-N 1-phenyl-4-[2-(5-phenylthiophen-2-yl)propyl]piperazine Chemical compound C=1C=C(C=2C=CC=CC=2)SC=1C(C)CN(CC1)CCN1C1=CC=CC=C1 RAMJEMMYMBYKBU-UHFFFAOYSA-N 0.000 description 1
- YBGXWDOUCLDSBT-UHFFFAOYSA-N 2-(bromomethyl)-5-[3-(trifluoromethyl)phenyl]furan Chemical compound FC(F)(F)C1=CC=CC(C=2OC(CBr)=CC=2)=C1 YBGXWDOUCLDSBT-UHFFFAOYSA-N 0.000 description 1
- UCLTZKFBJAFGCD-UHFFFAOYSA-N 2-(chloromethyl)-5-phenyl-1,3-oxazole Chemical compound O1C(CCl)=NC=C1C1=CC=CC=C1 UCLTZKFBJAFGCD-UHFFFAOYSA-N 0.000 description 1
- LOCNKPYHKGHOBU-UHFFFAOYSA-N 2-[(4-phenylpiperazin-1-yl)methyl]-4-[3-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound FC(F)(F)C1=CC=CC(C=2N=C(CN3CCN(CC3)C=3C=CC=CC=3)SC=2)=C1 LOCNKPYHKGHOBU-UHFFFAOYSA-N 0.000 description 1
- XHHSCKDSDWPGSV-UHFFFAOYSA-N 2-[[4-(2,4-dimethoxyphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound COC1=CC(OC)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 XHHSCKDSDWPGSV-UHFFFAOYSA-N 0.000 description 1
- KUZQCXQZOCCOIN-UHFFFAOYSA-N 2-[[4-(3,4-dichlorophenyl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole Chemical compound C1=C(Cl)C(Cl)=CC=C1N1CCN(CC=2SC=C(N=2)C=2C=CC=CC=2)CC1 KUZQCXQZOCCOIN-UHFFFAOYSA-N 0.000 description 1
- QIWYFEKTGQRVPI-UHFFFAOYSA-N 2-[[4-(3,4-dichlorophenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=C(Cl)C(Cl)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 QIWYFEKTGQRVPI-UHFFFAOYSA-N 0.000 description 1
- YAEGFWHPTUJTAZ-UHFFFAOYSA-N 2-[[4-(3,4-dimethoxyphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 YAEGFWHPTUJTAZ-UHFFFAOYSA-N 0.000 description 1
- RLHKLPBQRCSOEJ-UHFFFAOYSA-N 2-[[4-(3-bromophenyl)piperazin-1-yl]methyl]-4-(4-chlorophenyl)-1,3-thiazole Chemical compound C1=CC(Cl)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=C(Br)C=CC=2)=N1 RLHKLPBQRCSOEJ-UHFFFAOYSA-N 0.000 description 1
- YVCDRBYDQQZVOV-UHFFFAOYSA-N 2-[[4-(3-bromophenyl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole Chemical compound BrC1=CC=CC(N2CCN(CC=3SC=C(N=3)C=3C=CC=CC=3)CC2)=C1 YVCDRBYDQQZVOV-UHFFFAOYSA-N 0.000 description 1
- UXEFBKBZWNCLHW-UHFFFAOYSA-N 2-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound ClC1=CC=CC(N2CCN(CC=3OC(=CN=3)C=3C=CC=CC=3)CC2)=C1 UXEFBKBZWNCLHW-UHFFFAOYSA-N 0.000 description 1
- VGHUEAOJYRBZPO-UHFFFAOYSA-N 2-[[4-(3-methoxyphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound COC1=CC=CC(N2CCN(CC=3OC(=CN=3)C=3C=CC=CC=3)CC2)=C1 VGHUEAOJYRBZPO-UHFFFAOYSA-N 0.000 description 1
- ILOOKVCTLHDKDI-UHFFFAOYSA-N 2-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=CC(Cl)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 ILOOKVCTLHDKDI-UHFFFAOYSA-N 0.000 description 1
- ZRQKJDKAHQCXQU-UHFFFAOYSA-N 2-[[4-(4-ethoxyphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=CC(OCC)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 ZRQKJDKAHQCXQU-UHFFFAOYSA-N 0.000 description 1
- NLFLGBXEOYYPRB-UHFFFAOYSA-N 2-[[4-(4-methoxyphenyl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole Chemical compound C1=CC(OC)=CC=C1N1CCN(CC=2SC=C(N=2)C=2C=CC=CC=2)CC1 NLFLGBXEOYYPRB-UHFFFAOYSA-N 0.000 description 1
- HRMZSFCLOSTBFD-UHFFFAOYSA-N 2-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole Chemical compound C1=CC(C)=CC=C1N1CCN(CC=2SC=C(N=2)C=2C=CC=CC=2)CC1 HRMZSFCLOSTBFD-UHFFFAOYSA-N 0.000 description 1
- JUSDHZJXSNQIQW-UHFFFAOYSA-N 2-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=CC(C)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 JUSDHZJXSNQIQW-UHFFFAOYSA-N 0.000 description 1
- UQVVTMLGONPDGU-UHFFFAOYSA-N 2-[[4-(4-nitrophenyl)piperazin-1-yl]methyl]-5-phenyl-1,3-oxazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 UQVVTMLGONPDGU-UHFFFAOYSA-N 0.000 description 1
- CDCORJQYMWRNFM-UHFFFAOYSA-N 2-[[4-[4-chloro-3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-4-phenyl-1,3-thiazole Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(N2CCN(CC=3SC=C(N=3)C=3C=CC=CC=3)CC2)=C1 CDCORJQYMWRNFM-UHFFFAOYSA-N 0.000 description 1
- OBQYFPBESLPHHK-UHFFFAOYSA-N 2-benzyl-4-(chloromethyl)-1,3-thiazole Chemical compound ClCC1=CSC(CC=2C=CC=CC=2)=N1 OBQYFPBESLPHHK-UHFFFAOYSA-N 0.000 description 1
- BAEORBQOPCVJAH-UHFFFAOYSA-N 2-benzyl-4-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C=1SC(CC=2C=CC=CC=2)=NC=1CN(CC1)CCN1C1=CC=CC=C1 BAEORBQOPCVJAH-UHFFFAOYSA-N 0.000 description 1
- PRBQYQGNUJJMGL-UHFFFAOYSA-N 2-benzyl-4-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1,3-thiazole Chemical compound C1=CC(Cl)=CC=C1N1CCN(CC=2N=C(CC=3C=CC=CC=3)SC=2)CC1 PRBQYQGNUJJMGL-UHFFFAOYSA-N 0.000 description 1
- HBAYAOMQRIVASN-UHFFFAOYSA-N 2-benzyl-4-[[4-[4-chloro-3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-1,3-thiazole Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(N2CCN(CC=3N=C(CC=4C=CC=CC=4)SC=3)CC2)=C1 HBAYAOMQRIVASN-UHFFFAOYSA-N 0.000 description 1
- VONWPEXRCLHKRJ-UHFFFAOYSA-N 2-chloro-n-phenylacetamide Chemical compound ClCC(=O)NC1=CC=CC=C1 VONWPEXRCLHKRJ-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- XHBBTZZSXYLCPO-UHFFFAOYSA-N 2-propyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-1,3-thiazole;hydrochloride Chemical compound Cl.S1C(CCC)=NC(CN2CCN(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1 XHBBTZZSXYLCPO-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- JKBUDDSGMWGQDN-UHFFFAOYSA-N 3-(5-phenylfuran-2-yl)propanoic acid Chemical compound O1C(CCC(=O)O)=CC=C1C1=CC=CC=C1 JKBUDDSGMWGQDN-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- LPVAUTDBCYXZCP-UHFFFAOYSA-N 3-bromo-n-phenylpropanamide Chemical compound BrCCC(=O)NC1=CC=CC=C1 LPVAUTDBCYXZCP-UHFFFAOYSA-N 0.000 description 1
- SJWWDZZBCZRTLR-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 SJWWDZZBCZRTLR-UHFFFAOYSA-N 0.000 description 1
- WHJZYKXVBKGMQW-UHFFFAOYSA-N 4-(3-chlorophenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound ClC1=CC=CC(C=2N=C(CN3CCN(CC3)C=3C=CC=CC=3)SC=2)=C1 WHJZYKXVBKGMQW-UHFFFAOYSA-N 0.000 description 1
- OHHXDDQAYYLJHP-UHFFFAOYSA-N 4-(4-bromophenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=CC(Br)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 OHHXDDQAYYLJHP-UHFFFAOYSA-N 0.000 description 1
- MAFYEMDXRHYMBB-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=CC(Cl)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 MAFYEMDXRHYMBB-UHFFFAOYSA-N 0.000 description 1
- CLNIDZVNYQPGSW-UHFFFAOYSA-N 4-(4-methoxyphenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=CC(OC)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 CLNIDZVNYQPGSW-UHFFFAOYSA-N 0.000 description 1
- CYDYGBNINYGHQW-UHFFFAOYSA-N 4-(4-methylphenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 CYDYGBNINYGHQW-UHFFFAOYSA-N 0.000 description 1
- GCLVLSDQYXXNQV-UHFFFAOYSA-N 4-(4-nitrophenyl)-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 GCLVLSDQYXXNQV-UHFFFAOYSA-N 0.000 description 1
- CSTGNMKKUNFVGV-UHFFFAOYSA-N 4-(chloromethyl)-2-propan-2-yl-1,3-thiazole;hydrochloride Chemical compound Cl.CC(C)C1=NC(CCl)=CS1 CSTGNMKKUNFVGV-UHFFFAOYSA-N 0.000 description 1
- PAZHFVKPFFPSEK-UHFFFAOYSA-N 4-(chloromethyl)-2-propyl-1,3-thiazole Chemical compound CCCC1=NC(CCl)=CS1 PAZHFVKPFFPSEK-UHFFFAOYSA-N 0.000 description 1
- PYIJAXANUIAZFV-UHFFFAOYSA-N 4-[(4-phenylpiperazin-1-yl)methyl]-2-propan-2-yl-1,3-thiazole Chemical compound S1C(C(C)C)=NC(CN2CCN(CC2)C=2C=CC=CC=2)=C1 PYIJAXANUIAZFV-UHFFFAOYSA-N 0.000 description 1
- HTZIDQUQUWACHS-UHFFFAOYSA-N 4-[2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazol-4-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=CSC(CN2CCN(CC2)C=2C=CC=CC=2)=N1 HTZIDQUQUWACHS-UHFFFAOYSA-N 0.000 description 1
- BWKWRXHQZMILBR-UHFFFAOYSA-N 4-[4-[(5-phenyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]phenol Chemical compound C1=CC(O)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 BWKWRXHQZMILBR-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- FVZMZBJDCFYZEZ-UHFFFAOYSA-N 4-[[4-(3,4-dichlorophenyl)piperazin-1-yl]methyl]-2-propyl-1,3-thiazole;dihydrochloride Chemical compound Cl.Cl.S1C(CCC)=NC(CN2CCN(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 FVZMZBJDCFYZEZ-UHFFFAOYSA-N 0.000 description 1
- YDHVXDUDGQCRLY-UHFFFAOYSA-N 4-[[4-(3-bromophenyl)piperazin-1-yl]methyl]-2-propan-2-yl-1,3-thiazole Chemical compound S1C(C(C)C)=NC(CN2CCN(CC2)C=2C=C(Br)C=CC=2)=C1 YDHVXDUDGQCRLY-UHFFFAOYSA-N 0.000 description 1
- CECSIULZSTVBIM-UHFFFAOYSA-N 4-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-2-methyl-1,3-thiazole Chemical compound S1C(C)=NC(CN2CCN(CC2)C=2C=C(Cl)C=CC=2)=C1 CECSIULZSTVBIM-UHFFFAOYSA-N 0.000 description 1
- KLCPCQWDQHLFKX-UHFFFAOYSA-N 4-[[4-(3-methoxyphenyl)piperazin-1-yl]methyl]-2-methyl-1,3-thiazole Chemical compound COC1=CC=CC(N2CCN(CC=3N=C(C)SC=3)CC2)=C1 KLCPCQWDQHLFKX-UHFFFAOYSA-N 0.000 description 1
- HPOMFKRVZBGLJE-UHFFFAOYSA-N 4-[[4-(3-methoxyphenyl)piperazin-1-yl]methyl]-2-propan-2-yl-1,3-thiazole Chemical compound COC1=CC=CC(N2CCN(CC=3N=C(SC=3)C(C)C)CC2)=C1 HPOMFKRVZBGLJE-UHFFFAOYSA-N 0.000 description 1
- RIURGDOBCVLABX-UHFFFAOYSA-N 4-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-2-methyl-1,3-thiazole Chemical compound S1C(C)=NC(CN2CCN(CC2)C=2C=CC(Cl)=CC=2)=C1 RIURGDOBCVLABX-UHFFFAOYSA-N 0.000 description 1
- SJFQTVBODOORID-UHFFFAOYSA-N 4-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-2-propan-2-yl-1,3-thiazole Chemical compound S1C(C(C)C)=NC(CN2CCN(CC2)C=2C=CC(Cl)=CC=2)=C1 SJFQTVBODOORID-UHFFFAOYSA-N 0.000 description 1
- CQKXKGAVESUQSS-UHFFFAOYSA-N 4-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-2-propyl-1,3-thiazole Chemical compound S1C(CCC)=NC(CN2CCN(CC2)C=2C=CC(Cl)=CC=2)=C1 CQKXKGAVESUQSS-UHFFFAOYSA-N 0.000 description 1
- FBTGDXNZXITBQO-UHFFFAOYSA-N 4-[[4-(4-methoxyphenyl)piperazin-1-yl]methyl]-2-methyl-1,3-thiazole;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1N1CCN(CC=2N=C(C)SC=2)CC1 FBTGDXNZXITBQO-UHFFFAOYSA-N 0.000 description 1
- BYWIHRFBNICHPN-UHFFFAOYSA-N 4-[[4-(4-methoxyphenyl)piperazin-1-yl]methyl]-2-propyl-1,3-thiazole Chemical compound S1C(CCC)=NC(CN2CCN(CC2)C=2C=CC(OC)=CC=2)=C1 BYWIHRFBNICHPN-UHFFFAOYSA-N 0.000 description 1
- SPVXFQITANAAIR-UHFFFAOYSA-N 4-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-2-propyl-1,3-thiazole Chemical compound S1C(CCC)=NC(CN2CCN(CC2)C=2C=CC(C)=CC=2)=C1 SPVXFQITANAAIR-UHFFFAOYSA-N 0.000 description 1
- ARIYMLOOORSMOD-UHFFFAOYSA-N 4-[[4-[4-chloro-3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2-methyl-1,3-thiazole;hydrochloride Chemical compound Cl.S1C(C)=NC(CN2CCN(CC2)C=2C=C(C(Cl)=CC=2)C(F)(F)F)=C1 ARIYMLOOORSMOD-UHFFFAOYSA-N 0.000 description 1
- HNQHVKVZONCJES-UHFFFAOYSA-N 4-[[4-[4-chloro-3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2-propyl-1,3-thiazole;dihydrochloride Chemical compound Cl.Cl.S1C(CCC)=NC(CN2CCN(CC2)C=2C=C(C(Cl)=CC=2)C(F)(F)F)=C1 HNQHVKVZONCJES-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- TUFYTBLUQVDMST-UHFFFAOYSA-N 4-phenyl-2-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazole Chemical compound N=1C(C=2C=CC=CC=2)=CSC=1CN(CC1)CCN1C1=CC=CC=C1 TUFYTBLUQVDMST-UHFFFAOYSA-N 0.000 description 1
- GUEMVXABXIIEHY-UHFFFAOYSA-N 4-phenyl-2-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-1,3-thiazole Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC=3SC=C(N=3)C=3C=CC=CC=3)CC2)=C1 GUEMVXABXIIEHY-UHFFFAOYSA-N 0.000 description 1
- VAVOYRCCWLRTMS-UHFFFAOYSA-N 4-piperazin-1-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCNCC1 VAVOYRCCWLRTMS-UHFFFAOYSA-N 0.000 description 1
- ZAMWWGYBPMCJPS-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)furan-2-carbaldehyde Chemical compound C1=C(C)C(C)=CC=C1C1=CC=C(C=O)O1 ZAMWWGYBPMCJPS-UHFFFAOYSA-N 0.000 description 1
- WSYIKVIZVOMSLK-UHFFFAOYSA-N 5-phenyl-2-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-1,3-oxazole Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC=3OC(=CN=3)C=3C=CC=CC=3)CC2)=C1 WSYIKVIZVOMSLK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- SYIQBGCPEBWONQ-UHFFFAOYSA-N C1(=CC=CC=C1)C1=CC=C(O1)C(=O)N1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F.C1(=CC=CC=C1)C1=CC=C(O1)CN1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F Chemical compound C1(=CC=CC=C1)C1=CC=C(O1)C(=O)N1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F.C1(=CC=CC=C1)C1=CC=C(O1)CN1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F SYIQBGCPEBWONQ-UHFFFAOYSA-N 0.000 description 1
- QRBHSBJDOPSQQV-UHFFFAOYSA-N C1=CC(C)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=CC=CC=2)CC1 Chemical compound C1=CC(C)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=CC=CC=2)CC1 QRBHSBJDOPSQQV-UHFFFAOYSA-N 0.000 description 1
- ORDFBXJCKIKUJS-UHFFFAOYSA-N C1CN(C(CN1C2=CC(=CC=C2)Br)C(=O)C3=CC=CO3)C4=CC=C(C=C4)Cl Chemical compound C1CN(C(CN1C2=CC(=CC=C2)Br)C(=O)C3=CC=CO3)C4=CC=C(C=C4)Cl ORDFBXJCKIKUJS-UHFFFAOYSA-N 0.000 description 1
- MGCHUYZSGYMNQK-UHFFFAOYSA-N C1CN(CCN1CC2=CSC(=N2)CC3=CC=CC=C3)C4=CC(=CC=C4)Cl Chemical compound C1CN(CCN1CC2=CSC(=N2)CC3=CC=CC=C3)C4=CC(=CC=C4)Cl MGCHUYZSGYMNQK-UHFFFAOYSA-N 0.000 description 1
- QLTUBADHOYYWCR-UHFFFAOYSA-N CC1=CC(=CN1)CN2CCN(CC2)C3=CC=CC=C3Br Chemical compound CC1=CC(=CN1)CN2CCN(CC2)C3=CC=CC=C3Br QLTUBADHOYYWCR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 241000630524 Taractes rubescens Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- XPXRIFIZAIPZDF-UHFFFAOYSA-N [5-[3-(trifluoromethyl)phenyl]furan-2-yl]methanol Chemical compound O1C(CO)=CC=C1C1=CC=CC(C(F)(F)F)=C1 XPXRIFIZAIPZDF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005422 alkyl sulfonamido group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- AJEHNBIPLQJTNU-UHFFFAOYSA-N cyanomethyl acetate Chemical compound CC(=O)OCC#N AJEHNBIPLQJTNU-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N hydroxymaleic acid group Chemical group O/C(/C(=O)O)=C/C(=O)O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- LQLTYMKINLYYGJ-UHFFFAOYSA-N n-[4-[4-[(5-phenyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1N1CCN(CC=2OC(=CN=2)C=2C=CC=CC=2)CC1 LQLTYMKINLYYGJ-UHFFFAOYSA-N 0.000 description 1
- MQPWLLHNXPHESA-UHFFFAOYSA-N n-[4-[4-[(5-phenylfuran-2-yl)methyl]piperazin-1-yl]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1N1CCN(CC=2OC(=CC=2)C=2C=CC=CC=2)CC1 MQPWLLHNXPHESA-UHFFFAOYSA-N 0.000 description 1
- DEGXEBQXKJOSTK-UHFFFAOYSA-N n-[4-[4-[(5-phenylthiophen-2-yl)methyl]piperazin-1-yl]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1N1CCN(CC=2SC(=CC=2)C=2C=CC=CC=2)CC1 DEGXEBQXKJOSTK-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000002916 oxazoles Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- XVSFHIIADLZQJP-UHFFFAOYSA-M sodium;propane-1-thiolate Chemical compound [Na+].CCC[S-] XVSFHIIADLZQJP-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003511 tertiary amides Chemical class 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1652676 | 1976-04-23 | ||
| GB16526/76A GB1575904A (en) | 1976-04-23 | 1976-04-23 | Phenyl piperazines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI771287A7 FI771287A7 (cs) | 1977-10-24 |
| FI63937B FI63937B (fi) | 1983-05-31 |
| FI63937C true FI63937C (fi) | 1983-09-12 |
Family
ID=10078930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI771287A FI63937C (fi) | 1976-04-23 | 1977-04-22 | Foerfarande foer framstaellning av terapeutiskt anvaendbara feylpiperaziner |
Country Status (34)
| Country | Link |
|---|---|
| JP (1) | JPS52151183A (cs) |
| AR (2) | AR222003A1 (cs) |
| AT (1) | AT355579B (cs) |
| AU (1) | AU514822B2 (cs) |
| BE (1) | BE853899A (cs) |
| BG (2) | BG27746A3 (cs) |
| CA (1) | CA1087617A (cs) |
| CH (2) | CH625802A5 (cs) |
| CS (1) | CS196360B2 (cs) |
| DD (1) | DD129790A5 (cs) |
| DE (1) | DE2717415A1 (cs) |
| DK (1) | DK176177A (cs) |
| ES (2) | ES457988A1 (cs) |
| FI (1) | FI63937C (cs) |
| FR (1) | FR2348925A1 (cs) |
| GB (1) | GB1575904A (cs) |
| GR (1) | GR64084B (cs) |
| HU (1) | HU176820B (cs) |
| IE (1) | IE44730B1 (cs) |
| IL (1) | IL51787A (cs) |
| LU (1) | LU77170A1 (cs) |
| MX (1) | MX4596E (cs) |
| NL (1) | NL7704456A (cs) |
| NO (1) | NO146710C (cs) |
| NZ (1) | NZ183715A (cs) |
| OA (1) | OA05643A (cs) |
| PH (1) | PH14124A (cs) |
| PL (1) | PL117466B1 (cs) |
| PT (1) | PT66452B (cs) |
| RO (1) | RO72831A (cs) |
| SE (1) | SE7704536L (cs) |
| SU (2) | SU664564A3 (cs) |
| YU (1) | YU104477A (cs) |
| ZA (1) | ZA771849B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
| DE3142608A1 (de) * | 1981-10-28 | 1983-05-05 | Basf Ag, 6700 Ludwigshafen | Polyazofarbstoffe |
| JPH07157477A (ja) * | 1993-12-02 | 1995-06-20 | Asahi Kagaku Kogyo Kk | チアゾール誘導体の製造方法 |
| AU686340B2 (en) * | 1994-03-11 | 1998-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | 5-HT3 receptor agonist, novel thiazole derivative, and intermediate therefor |
| CA2144669A1 (en) * | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| DZ3292A1 (fr) * | 2001-09-13 | 2005-05-14 | Solvay Pharm Gmbh | Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes |
| US8927546B2 (en) | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| TW200804309A (en) | 2006-02-28 | 2008-01-16 | Helicon Therapeutics Inc | Therapeutic piperazines |
-
1976
- 1976-04-23 GB GB16526/76A patent/GB1575904A/en not_active Expired
-
1977
- 1977-03-28 ZA ZA00771849A patent/ZA771849B/xx unknown
- 1977-03-28 NZ NZ183715A patent/NZ183715A/xx unknown
- 1977-03-30 IL IL51787A patent/IL51787A/xx unknown
- 1977-03-30 IE IE671/77A patent/IE44730B1/en unknown
- 1977-03-30 CA CA275,160A patent/CA1087617A/en not_active Expired
- 1977-04-13 CH CH455777A patent/CH625802A5/fr not_active IP Right Cessation
- 1977-04-13 CH CH525781A patent/CH633009A5/fr not_active IP Right Cessation
- 1977-04-13 MX MX775629U patent/MX4596E/es unknown
- 1977-04-14 PH PH19656A patent/PH14124A/en unknown
- 1977-04-18 PT PT66452A patent/PT66452B/pt unknown
- 1977-04-18 AU AU24386/77A patent/AU514822B2/en not_active Expired
- 1977-04-19 GR GR53236A patent/GR64084B/el unknown
- 1977-04-19 FR FR7711669A patent/FR2348925A1/fr active Granted
- 1977-04-20 ES ES457988A patent/ES457988A1/es not_active Expired
- 1977-04-20 BG BG036062A patent/BG27746A3/xx unknown
- 1977-04-20 RO RO7790106A patent/RO72831A/ro unknown
- 1977-04-20 BG BG037191A patent/BG28055A3/xx unknown
- 1977-04-20 OA OA56149A patent/OA05643A/xx unknown
- 1977-04-20 DE DE19772717415 patent/DE2717415A1/de not_active Withdrawn
- 1977-04-20 SE SE7704536A patent/SE7704536L/xx not_active Application Discontinuation
- 1977-04-21 LU LU77170A patent/LU77170A1/xx unknown
- 1977-04-21 DK DK176177A patent/DK176177A/da not_active Application Discontinuation
- 1977-04-21 YU YU01044/77A patent/YU104477A/xx unknown
- 1977-04-21 CS CS772668A patent/CS196360B2/cs unknown
- 1977-04-22 HU HU77LI311A patent/HU176820B/hu unknown
- 1977-04-22 NL NL7704456A patent/NL7704456A/xx not_active Application Discontinuation
- 1977-04-22 AT AT285177A patent/AT355579B/de not_active IP Right Cessation
- 1977-04-22 FI FI771287A patent/FI63937C/fi not_active IP Right Cessation
- 1977-04-22 PL PL1977197550A patent/PL117466B1/pl unknown
- 1977-04-22 DD DD7700198558A patent/DD129790A5/xx unknown
- 1977-04-22 SU SU772474105A patent/SU664564A3/ru active
- 1977-04-22 BE BE6045977A patent/BE853899A/xx not_active IP Right Cessation
- 1977-04-22 AR AR267310A patent/AR222003A1/es active
- 1977-04-22 NO NO771398A patent/NO146710C/no unknown
- 1977-04-23 JP JP4727677A patent/JPS52151183A/ja active Pending
- 1977-12-28 SU SU772558499A patent/SU727146A3/ru active
-
1978
- 1978-03-16 ES ES467948A patent/ES467948A1/es not_active Expired
- 1978-03-22 AR AR271519A patent/AR222635A1/es active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2080321C1 (ru) | Азотсодержащие гетероциклические соединения в виде рацемата или отдельных энантиомеров, являющиеся ингибиторами биосинтеза лейкотриена | |
| CA1190224A (en) | Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists | |
| DK145297B (da) | Analogifremgangsmaade til fremstilling af 2h-1,2-benzothiazin-1,1-dioxid-derivater eller tautomere eller basesalte deraf | |
| CS227015B2 (en) | Method of preparing 2,4-di-substituted thiazol derivatives | |
| HU188852B (en) | Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer | |
| FI63937C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara feylpiperaziner | |
| KR20080003380A (ko) | 우레아 유도체들, 그 제조방법 및 그 이용 | |
| DD215544A5 (de) | Verfahren zur herstellung von dihydropyridinen | |
| SU795462A3 (ru) | Способ получени тиокарбамидныхпРОизВОдНыХ | |
| US4123529A (en) | Phenylpiperazine derivatives | |
| US2748125A (en) | 1-substituted-4-sulfamylpiperazine and method of preparing the same | |
| US4522943A (en) | Chemical compounds | |
| Kumar et al. | Syntheses and anthelmintic activity of alkyl 5 (6)-(substituted carbamoyl)-and 5 (6)-(disubstituted carbamoyl) benzimidazole-2-carbamates and related compounds | |
| US3236855A (en) | Certain n-phenyl(thiazole-hydroxamidine) compounds and their preparation | |
| US4526973A (en) | Chemical compounds | |
| US4261994A (en) | 1,2,4-Oxadiazole derivatives, their preparation and pharmaceutical use | |
| US20080070946A1 (en) | Hydroxymethylbenzothiazoles Amides | |
| DK170047B1 (da) | Med basiske heterocycliske grupper substituerede 5-halogen-thienoisothiazol-3(2H)-on-1,1-dioxider og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser, farmaceutiske præparater indeholdende disse forbindelser og forbindelsernes anvendelse ved fremstilling af lægemidler til behandling af angsttilstande | |
| PL94923B1 (cs) | ||
| EA035946B1 (ru) | Способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она | |
| US3106553A (en) | Nu-2-propynyl alkylenediamines | |
| FI77238B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla fenylalkyl(piperazinyl eller homopiperazinyl)alkyltioler eller tiokarbamater. | |
| US3969351A (en) | Morpholine containing isothiocyanobenzoxazoles | |
| US2535971A (en) | 1-carbalkoxy-4-substituted piperazines | |
| CS236788B2 (en) | Processing of thiazoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: LILLY INDUSTRIES LIMITED |